These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22090135)

  • 1. The cellular antiviral restriction factor tetherin does not inhibit poxviral replication.
    Sliva K; Resch T; Kraus B; Goffinet C; Keppler OT; Schnierle BS
    J Virol; 2012 Feb; 86(3):1893-6. PubMed ID: 22090135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catch Me if You Can: the Crosstalk of Zika Virus and the Restriction Factor Tetherin.
    Herrlein ML; Schmanke P; Elgner F; Sabino C; Akhras S; Bender D; Glitscher M; Tabari D; Scholl C; Stingl J; Hildt E
    J Virol; 2022 Feb; 96(4):e0211721. PubMed ID: 34935441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Host Restriction Factor Interferon-Inducible Transmembrane Protein 3 Inhibits Vaccinia Virus Infection.
    Li C; Du S; Tian M; Wang Y; Bai J; Tan P; Liu W; Yin R; Wang M; Jiang Y; Li Y; Zhu N; Zhu Y; Li T; Wu S; Jin N; He F
    Front Immunol; 2018; 9():228. PubMed ID: 29503647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Interferon-Inducible Protein Tetherin Inhibits Hepatitis B Virus Virion Secretion.
    Yan R; Zhao X; Cai D; Liu Y; Block TM; Guo JT; Guo H
    J Virol; 2015 Sep; 89(18):9200-12. PubMed ID: 26109732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Vertebrate Evolution of the Host Restriction Factor Tetherin.
    Heusinger E; Kluge SF; Kirchhoff F; Sauter D
    J Virol; 2015 Dec; 89(23):12154-65. PubMed ID: 26401043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccinia Virus BBK E3 Ligase Adaptor A55 Targets Importin-Dependent NF-κB Activation and Inhibits CD8
    Pallett MA; Ren H; Zhang RY; Scutts SR; Gonzalez L; Zhu Z; Maluquer de Motes C; Smith GL
    J Virol; 2019 May; 93(10):. PubMed ID: 30814284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetherin and its viral antagonists.
    Kuhl BD; Cheng V; Wainberg MA; Liang C
    J Neuroimmune Pharmacol; 2011 Jun; 6(2):188-201. PubMed ID: 21222046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.
    Kaletsky RL; Francica JR; Agrawal-Gamse C; Bates P
    Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2886-91. PubMed ID: 19179289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza virus partially counteracts restriction imposed by tetherin/BST-2.
    Mangeat B; Cavagliotti L; Lehmann M; Gers-Huber G; Kaur I; Thomas Y; Kaiser L; Piguet V
    J Biol Chem; 2012 Jun; 287(26):22015-29. PubMed ID: 22493439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Restriction Factors by Human Genome-Wide RNA Interference Screening of Viral Host Range Mutants Exemplified by Discovery of SAMD9 and WDR6 as Inhibitors of the Vaccinia Virus K1L-C7L- Mutant.
    Sivan G; Ormanoglu P; Buehler EC; Martin SE; Moss B
    mBio; 2015 Aug; 6(4):e01122. PubMed ID: 26242627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limiting Respiratory Viral Infection by Targeting Antiviral and Immunological Functions of BST-2/Tetherin: Knowledge and Gaps.
    Berry KN; Kober DL; Su A; Brett TJ
    Bioessays; 2018 Oct; 40(10):e1800086. PubMed ID: 30113067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RAB1A promotes Vaccinia virus replication by facilitating the production of intracellular enveloped virions.
    Pechenick Jowers T; Featherstone RJ; Reynolds DK; Brown HK; James J; Prescott A; Haga IR; Beard PM
    Virology; 2015 Jan; 475():66-73. PubMed ID: 25462347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposing Roles of Double-Stranded RNA Effector Pathways and Viral Defense Proteins Revealed with CRISPR-Cas9 Knockout Cell Lines and Vaccinia Virus Mutants.
    Liu R; Moss B
    J Virol; 2016 Sep; 90(17):7864-79. PubMed ID: 27334583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin.
    Jouvenet N; Neil SJ; Zhadina M; Zang T; Kratovac Z; Lee Y; McNatt M; Hatziioannou T; Bieniasz PD
    J Virol; 2009 Feb; 83(4):1837-44. PubMed ID: 19036818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetherin has negligible activity in restricting hepatitis C virus in hepatocytes.
    Ye L; Wang X; Li J; Liu J; Ramirez SH; Wu J; Ho W
    Innate Immun; 2012 Jun; 18(3):398-405. PubMed ID: 21940748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Vaccinia Virus (VACV) B1 and Cellular VRK2 Kinases Promote VACV Replication Factory Formation through Phosphorylation-Dependent Inhibition of VACV B12.
    Rico AB; Wang Z; Olson AT; Linville AC; Bullard BL; Weaver EA; Jones C; Wiebe MS
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31341052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of the
    Bravo Cruz AG; Han A; Roy EJ; Guzmán AB; Miller RJ; Driskell EA; O'Brien WD; Shisler JL
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28490586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice.
    Chen NG; Yu YA; Zhang Q; Szalay AA
    J Transl Med; 2011 Sep; 9():164. PubMed ID: 21951588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccinia virus E3 protein prevents the antiviral action of ISG15.
    Guerra S; Cáceres A; Knobeloch KP; Horak I; Esteban M
    PLoS Pathog; 2008 Jul; 4(7):e1000096. PubMed ID: 18604270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of retroviral restriction factors involved in resistance to porcine endogenous retrovirus.
    Bae EH; Jung YT
    J Microbiol Biotechnol; 2014 Apr; 24(4):577-83. PubMed ID: 24448163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.